Insider · CIK 0001612551

Munshi Amit

Reports to the SEC for 8 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001612551

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+155K sh	—	—	155,000
2026-06-17	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+51K sh	—	—	51,000
2026-06-05	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+5,778 sh	—	—	9,799
2026-06-05	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,667
2026-02-21	IKTInhibikase Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−19.1K sh	—	—	38,176
2025-12-04	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+2,021 sh	—	—	4,021
2025-12-04	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,502
2025-12-04	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,177 sh	—	—	6,177
2025-06-30	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+108K sh	—	—	108,176
2025-06-18	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+720 sh	—	—	720
2025-05-21	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+51K sh	—	—	51,000
2025-02-21	IKTInhibikase Therapeutics, Inc.A Award	Director	AAward	+57.3K sh	—	—	57,265
2025-02-14	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.6K sh	—	—	56,600
2025-02-14	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+117K sh	—	—	116,585
2024-12-09	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+117K sh	—	—	117,000
2024-10-21	IKTInhibikase Therapeutics, Inc.P Purchase	Director	PPurchase	+365K sh	$1.37	+$500K	365,000
2024-10-21	IKTInhibikase Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2024-06-20	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2024-04-22	ZURAZura Bio LtdA Award	Director	AAward	+160K sh	$3.13	+$500K	777,384
2024-04-22	ZURAZura Bio LtdP Purchase	Director	PPurchase	+160K sh	$3.13	+$500K	777,384
2023-06-14	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2023-06-05	ZURAZura Bio LtdP Purchase	Director	PPurchase	+118K sh	$4.25	+$500K	617,640
2023-06-01	ZURAZura Bio Ltd · Employee Share Option (Right to Buy)A Award	Director	AAward	+1.13M sh	—	—	1,130,000
2022-06-14	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director, President and CEO	JOther	−250 sh	—	—	114,647
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director, President and CEO	JOther	−28.8K sh	—	—	85,847
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director, President and CEO	JOther	−85.8K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−138K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−56.9K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−310K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−285K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−270K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−168K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−42K sh	—	—	0
2022-03-08	ARENA PHARMACEUTICALS INCG Gift	Director, President and CEO	GGift	−10.5K sh	$98.51	−$1.03M	114,897
2022-01-03	ARENA PHARMACEUTICALS INCA Award	Director, President and CEO	AAward	+85.8K sh	—	—	125,397
2021-08-16	ARENA PHARMACEUTICALS INCP Purchase	Director, President and CEO	PPurchase	+1,000 sh	$48.19	+$48.2K	39,550
2021-08-12	ARENA PHARMACEUTICALS INCP Purchase	Director, President and CEO	PPurchase	+1,000 sh	$50.41	+$50.4K	38,550
2021-08-10	ARENA PHARMACEUTICALS INCP Purchase	Director, President and CEO	PPurchase	+1,000 sh	$52.91	+$52.9K	37,550
2021-03-01	ARENA PHARMACEUTICALS INCA Award	Director, President and CEO	AAward	+28.8K sh	—	—	36,550
2021-03-01	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+168K sh	—	—	168,000
2021-03-01	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitA Award	Director, President and CEO	AAward	+42K sh	—	—	42,000
2021-01-28	PULMPulmatrix, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-01-19	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$15.50	+$775K	57,750
2021-01-19	ARENA PHARMACEUTICALS INCS Sale	Director, President and CEO	SSale	−50K sh	$80.14	−$4.01M	7,750
2021-01-19	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	138,139
2021-01-15	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$15.50	+$775K	57,750
2021-01-15	ARENA PHARMACEUTICALS INCS Sale	Director, President and CEO	SSale	−47.1K sh	$80.19	−$3.78M	10,650
2021-01-15	ARENA PHARMACEUTICALS INCS Sale	Director, President and CEO	SSale	−2,900 sh	$81.06	−$235K	7,750
2021-01-15	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	188,139

Recent filings

Accepted (ET)
Jun 304
Munshi Amit0001193125-26-290470
SEC(opens sec.gov)
Jun 224
Munshi Amit0001612551-26-000002
SEC(opens sec.gov)
Jun 94
Munshi Amit0001628280-26-042041
SEC(opens sec.gov)
Feb 244
Munshi Amit0001193125-26-068063
SEC(opens sec.gov)
Dec 84
Munshi Amit0001628280-25-055927
SEC(opens sec.gov)
Aug 284
Munshi Amit0001193125-25-191463
SEC(opens sec.gov)
Jul 24
Munshi Amit0000950170-25-093432
SEC(opens sec.gov)
Jun 204
Munshi Amit0000950170-25-088166
SEC(opens sec.gov)
May 224
Munshi Amit0001415889-25-014223
SEC(opens sec.gov)
Feb 194
Munshi Amit0000950170-25-023586
SEC(opens sec.gov)
Dec 114
Munshi Amit0001415889-24-028974
SEC(opens sec.gov)
Oct 234
Munshi Amit0000950170-24-116780
SEC(opens sec.gov)
Sep 64/A
Munshi Amit0001415889-24-023028
SEC(opens sec.gov)
Jun 214
Munshi Amit0000950170-24-076188
SEC(opens sec.gov)
Apr 244
Munshi Amit0001415889-24-011480
SEC(opens sec.gov)

Companies

Address

1000 N. WEST STREET, SUITE 1200

WILMINGTON, DE, 19801